mots c 5 amino 1mq 5-Amino-1MQ Peptide | 99%+ Purity 5-Amino-1MQ/NAD/MOTS-C Atomizer - Parabolic Research

Understanding these metabolic effects has implications for research into diabetes and related metabolic conditions

At the molecular level, 5-amino-1MQ functions as a competitive inhibitor of NNMT, demonstrating remarkable potency with an IC of 1.2 0.1 M under standard assay conditions (50 M SAM, 100 M nicotinic acid). This represents a dramatic 10-fold improvement over the parent compound 1-methylquinolinium, achieved through strategic amino group substitution that enhances binding affinity to the NNMT active site. The compound's mechanism centers on preventing the methylation of nicotinamide to 1-methylnicotinamide (1-MNA), thereby preserving nicotinamide for recycling back to NAD+ through the salvage pathway. This intervention effectively blocks what researchers have termed the "NNMT metabolic drain" a process that simultaneously depletes NAD+ precursors and consumes cellular methylation capacity

5-Amino-1MQ operates as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme central to regulating nicotinamide metabolism and intracellular NAD+ levels

Researchers at the University of Texas Medical Branch first characterized 5-amino-1mq in 2017 while searching for ways to inhibit NNMT, an enzyme they had identified as a key regulator of fat cell metabolism

NAD+ is the hinge

NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives immune evasion in urothelial carcinoma by elevating PD-L1 N-glycosylation